A small regulatory RNA controls antibiotic adaptation in Staphylococcus aureus by modulating efflux pump expression

Area of Science:

• Microbiology
• Molecular Biology
• Genetics

Background:

• Staphylococcus aureus is a major healthcare pathogen, exhibiting significant antibiotic resistance.
• Small regulatory RNAs (sRNAs) are key regulators of bacterial adaptation to environmental changes, including antibiotic exposure.
• Understanding sRNA roles in antibiotic resistance is vital for developing new therapeutic strategies.

Purpose of the Study:

• To investigate the role of sRNAs in Staphylococcus aureus adaptation to antibiotics.
• To identify specific sRNAs involved in resistance mechanisms against fluoroquinolone and beta-lactam antibiotics.
• To elucidate the regulatory pathway involving RsaA, MgrA, and antibiotic sensitivity.

Main Methods:

• Construction and fitness assessment of a library of sRNA mutants in Staphylococcus aureus.
• Phenotypic analysis of sRNA mutants' susceptibility to fluoroquinolone and beta-lactam antibiotics.
• Complementation studies using different forms of the RsaA gene to restore antibiotic sensitivity.

Main Results:

• RsaA sRNA is essential for optimal growth of Staphylococcus aureus in the presence of low-concentration fluoroquinolones.
• Absence of RsaA increases resistance to beta-lactam antibiotics.
• RsaA regulates antibiotic sensitivity through the master regulatory protein MgrA.
• The long form of RsaA, not the short form, is responsible for restoring the wild-type antibiotic sensitivity phenotype.

Conclusions:

• RsaA plays a significant role in Staphylococcus aureus adaptation to antibiotic stress.
• The long form of RsaA is critical for modulating sensitivity to fluoroquinolone and beta-lactam antibiotics via MgrA.
• sRNAs, particularly RsaA, represent promising therapeutic targets for enhancing the efficacy of existing antibiotics.